Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Acq. announced
|
Comera Life Sciences Holdings, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
8-K
| Quarterly results |
05/12/2023 |
8-K
| Quarterly results
Docs:
|
"Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights – Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of Comera’s pipeline candidate CLS-001 , highlighted by identification of a lead formulation – – Expanded Comera’s patent portfolio, broadening geographic coverage as well as scope of claims for core SQore™ excipient technology – WOBURN, Mass., May 11, 2023 — Comera Life Sciences Holdings, Inc. , a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today reported financial results for the first quarter ended March 31, 2023, and provided a business update. “..." |
|
03/16/2023 |
8-K
| Quarterly results |
|
|